ICD-10-CM Billable Code

Q99.812

Usher syndrome, type 2

Clinical Classification Guidelines

Medical Intelligence & Overview

Usher syndrome type 2 is a genetic disorder characterized by the combination of moderate to severe hearing loss from birth and progressive vision loss due to retinitis pigmentosa. It is one of the three types of Usher syndrome, a condition that affects both hearing and vision, leading to significant challenges in communication, mobility, and daily activities. Patients with this syndrome typically experience a gradual decline in their visual capabilities while their hearing impairment remains relatively stable. Early detection and supportive management can help improve quality of life for individuals with this condition.

Causes & Symptoms

Clinical Causes: Mutations in specific genes involved in the development and function of the inner ear and retina. Inheritance pattern is autosomal recessive, meaning a person must inherit two copies of the faulty gene (one from each parent) to be affected. Genetic testing can identify mutations responsible for the syndrome, although the exact gene involved can vary among individuals.

Key Symptoms: Hearing loss that is moderate to severe from a young age. Progressive loss of vision, often beginning with difficulty seeing in low light or at night. Night blindness, an early sign of retinitis pigmentosa. Gradual constriction of the visual field, leading to tunnel vision over time. Photophobia, sensitivity to bright lights that may develop as the condition progresses. Difficulty adapting to darkness and night vision problems may lead to challenges with mobility.

Diagnostic & Treatment

Diagnosis Path: Hearing tests (audiometry) to evaluate the degree of hearing impairment. Eye examinations, including visual field testing and electroretinography (ERG), to assess retinal function. Genetic testing to identify specific gene mutations associated with Usher syndrome type 2. Medical history review, focusing on hearing and vision changes from an early age.

Treatment Protocols: Hearing aids or cochlear implants to enhance hearing capabilities. Visual aids and specialized training to assist with remaining vision. Regular ophthalmologic and audiologic evaluations to monitor progression. Orientation and mobility training to assist with navigation and independence. Support services such as counseling and support groups for individuals and families affected by the syndrome. Potential future therapies, including gene therapy, are under research but are not yet widely available.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q99.812 a billable ICD-10 code?
Yes, Q99.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q99.812?
Clinical documentation must specify the nature of Usher syndrome, type 2 and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

usher